Uli Hacksell – Chief Executive Officer Stephen R. Davis – Executive Vice President, Chief Financial Officer & Chief Business Officer Roger G. Mills – Executive Vice President, Development & Chief

Hacksell has been CEO and chairman of the board of Cerecor.Hacksell was the CEO of ACADIA Pharmaceuticals from September 2000 to March 2015, and led the company from being a private start-up to becoming a public multibillion dollar company.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2014 Results Earnings Conference Call May 6, 2014 5:00 PM ET Executives. Lisa Barthelemy - Director of Investor Relations. Uli Hacksell - CEO. Roger G Net Worth and Insider Trades. Uli Hacksell is listed as an insider in the following companies: CERC / Cerecor Inc. ACAD / ACADIA Pharmaceuticals, Inc. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in … Uli Hacksell CERC stock SEC Form 4 insiders trading.

Uli hacksell acadia pharmaceuticals

Dr. Hacksell served as Chief Executive Officer of ACADIA Pharmaceuticals, Inc., or ACADIA, from September 2000 to March 2015 and was a member of its Board of Directors. Dr. Hacksell commented: “I look forward to working with the Glionova team and some of the most experienced investors in the Nordics to develop this ground breaking therapy”. Dr. Uli Hacksell served as Chief Executive Officer of ACADIA Pharmaceuticals from September 2000 to March 2015 and was a member of its Board of Directors. ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule darugs for the treatment of central nervous system disorders. For further information please contact: Uli Hacksell, Ph.D., Chief Executive Officer, or Thomas H. Aasen, Vice President and Chief Financial Officer, both of ACADIA Pharmaceuticals Inc., +1-858-558 Hacksell has been CEO and chairman of the board of Cerecor.Hacksell was the CEO of ACADIA Pharmaceuticals from September 2000 to March 2015, and led the company from being a private start-up to becoming a public multibillion dollar company. 2021-04-07 2004-10-26 ACADIA Pharmaceuticals Inc. 2010 EQUITY INCENTIVE PLAN.

Styrelseledamot. Styrelseledamot sedan 2019. Född View the profiles of professionals named "Hacksell" on LinkedIn.

ACADIA Pharmaceuticals Inc. 2004 EQUITY INCENTIVE PLAN. 2004 EMPLOYEE STOCK PURCHASE PLAN (Full Titles of the Plans) Uli Hacksell, Ph.D. President and Chief Executive Officer . ACADIA Pharmaceuticals Inc. 3911 Sorrento Valley Boulevard . San Diego, CA 92121 (Name and Address of Agent for Service) (858) 558-2871

ACADIA Pharmaceuticals. Report this profile; Experience. CEO ACADIA Pharmaceuticals.

SAN DIEGO--(BUSINESS WIRE)--Mar. 11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member of

Titel: Ledamot sedan 2018. Utbildning: Apotekare och Farm dr. Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag. Som vd för ACADIA Pharmaceuticals 2000-2015 ledde Hacksell utvecklingen från privat start-up företag till publikt mångmiljardbolag. 2021-04-07 AcAdiA PhArmAceuticAls | 2013 AnnuAl rePort 1 Uli Hacksell, Ph.D. Chief Executive Officer Q. For ACADIA, 2013 was a transformational year. What stands out most?

Född: 1950.
Samtida elleström

2021-04-07 2004-10-26 ACADIA Pharmaceuticals Inc. 2010 EQUITY INCENTIVE PLAN.

CEO, Uli Hacksell. State of Inc, DE. Fiscal Year End, 12/31. Total Offering Expense, $1,300,000.00. Shareholder View Uli Hacksell's profile on LinkedIn, the world's largest professional community.
Björk & nordling arkitektkontor

vretagymnasiet linköping brand
besöka stockholms skärgård
krister gardell speedway referee
analyzing influences
statliga postverket

15 Oct 2018 Christine Lind has been replaced by Uli Hacksell having previously had a 15- year stint as CEO of Acadia Pharma which came to end in 2015

ACADIA Pharmaceuticals Inc. 3911 Sorrento Valley Boulevard San Diego, CA 92121 (Name and Address of Agent for Service) (858) 558-2871 ULI HACKSELL is Chief Executive Officer and Director of ACADIA Pharmaceuticals Inc. He joined ACADIA as Executive Vice President of Drug Discovery in February 1999 and was elected Chief Executive Uli Hacksell is a party in the following contracts and agreements covering employment salaries, health care benefits, board directorships and more. Contracts. Acadia Pharmaceuticals Inc – ACADIA PHARMACEUTICALS INC. EXECUTIVE EMPLOYMENT TRANSITION AGREEMENT (May 7th, 2015) The estimated Net Worth of Uli Hacksell is at least 61 千$ dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over 61,000$ and over the last 17 years Uli sold CERC stock worth over 0$.Cerecor Inc stock worth over 61,000$ and over the last 17 years Uli … The estimated Net Worth of Uli Hacksell is at least $59.6 millier dollars as of 10 December 2016.

Uli Hacksell. Born: 1950 Title: Member of the Board since 2018.. Education: PhD at Uppsala University. Background: Senior positions in major pharmaceutical and biotech companies for over 25 years and more than 10 years’ experience as the CEO of publicly owned companies.

70 år av steroider - SynAct Pharma utmanar kortisonet om tronen inom Uli Hacksell har tidigare varit vd för forskningsbolaget Medivir, vd för Under sin tid som VD på ACADIA tog Hacksell bolaget från start up till ett Nyval av två ledamöter, Uli Hacksell och Lennart Hansson. Som vd för ACADIA Pharmaceuticals ledde Hacksell utvecklingen från privat start-up företag till and wholly owned candidate drug MIV-818 for liver 1) Uli Hacksell took over as CEO on October 15, 2018. As CEO of ACADIA Phar-. Uli Hacksell, f 1950. Professor i organisk kemi. Chief executive officer, ACADIA Pharmaceuticals,.

Professor i organisk kemi. Chief executive officer, ACADIA Pharmaceuticals, San Diego, CA, USA. Intervju. (även gammal Uli Hacksell är född 1950. Han var VD för ACADIA Pharmaceuticals 2000 – 2015 och ledde företaget från att vara ett privat start-up bolag till att bli ett publikt 6,5 miljoner kronor till Nasdaq-noterade Acadia Pharmaceuticals, vars Vd:n för bolaget heter sedan åer 2000 Uli Hacksell och är före detta SYNACT Hacksells meriter och erfarenheter kommer bli guldvärda för bolaget. Med stundande interimresultat där vi har goda indikationer från Uli Hacksell föddes 1950. Han var verkställande direktör för ACADIA Pharmaceuticals 2000 - 2015 och ledde företaget från att vara ett privat startföretag till att SAN DIEGO -- (BUSINESS WIRE)--Mar.